EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The role of the gut microbiome in disorders of gut–brain interaction

Brent J Gawey, Ruben A Mars, Purna C Kashyap iD

The FEBS Journal · 2025-03 · 292 (6) · 1357-1377

DOI: 10.1111/febs.17200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 23.06.2024. Verfasst von Brent J Gawey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disorders of Gut‐Brain Interaction (DGBI) are widely prevalent and commonly encountered in gastroenterology practice. While several peripheral and central mechanisms have been implicated in the pathogenesis of DGBI, a recent body of work suggests an important role for the gut microbiome. In this review, we highlight how gut microbiota and their metabolites affect physiologic changes underlying symptoms in DGBI, with a particular focus on their mechanistic influence on GI transit, visceral sensitivity, intestinal barrier function and secretion, and CNS processing. This review emphasizes the complexity of local and distant effects of microbial metabolites on physiological function, influenced by factors such as metabolite concentration, duration of metabolite exposure, receptor location, host genetics, and underlying disease state. Large‐scale in vitro work has elucidated interactions between host receptors and the microbial metabolome but there is a need for future research to integrate such preclinical findings with clinical studies. The development of novel, targeted therapeutic strategies for DGBI hinges on a deeper understanding of these metabolite‐host interactions, offering exciting possibilities for the future of treatment of DGBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBrainBrain-Gut AxisHumansAnimals

Stichwörter der Autor:innen

bile acidsdisorders of gut–brain interactionfunctional gastrointestinal disordersgut microbiomegut–brain axisindolemicrobial metabolismproteasesshort‐chain fatty acidstryptophan derivatives

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Purna C Kashyap

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Gawey, B. J., Mars, R. A., & Kashyap, P. C. (2025). The role of the gut microbiome in disorders of gut–brain interaction. The FEBS Journal, 292(6), 1357-1377. https://doi.org/10.1111/febs.17200

Vancouver

Gawey BJ, Mars RA, Kashyap PC. The role of the gut microbiome in disorders of gut–brain interaction. The FEBS Journal. 2025;292(6):1357-1377. doi:10.1111/febs.17200

BibTeX
@article{Gawey2025,
  author = {Gawey, Brent J and Mars, Ruben A and Kashyap, Purna C},
  title = {The role of the gut microbiome in disorders of gut–brain interaction},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {6},
  pages = {1357--1377},
  doi = {10.1111/febs.17200}
}
Kostenlos starten →